Tubing, Thermoplastic Tubing

Tygon® MPF-300 Tubing

Tygon® MPF-300 tubing is a clear, high-performance polymer not formulated with PVC or DEHP, however, trace levels of DEHP are not controlled. This flexible tubing is designed to replace PVC in medical devices in, which DEHP plasticizers and leachables are not desired. Tygon MPF-300 has excellent bonding strength and is ideally suited for fluid and oxygen administration applications. Tygon MPF-300 is developed specifically for medical applications and tested to various elements of ISO 10993 including hemocompatibility, implantation, irritation and skin sensitization, systemic toxicity, and cytotoxicity.

Increasing concerns in Europe and North America regarding health hazards and environmentally friendly disposal of DEHP plasticizers led to the development of the MPF product line. Tygon MPF-300 is designed and manufactured without the intentional addition of DEHP.

Tygon MPF-300 Product Details

Features & Benefits

  • PVC replacement - Tubing not made with plasticizers
  • Excellent chemical resistance
  • Cleanroom manufacutring available

Physical properties are not significantly impacted by the following sterilization methods:

  • Gas - EtO (Ethylene Oxide)
  • Radiation (25 kGy/2.5 Mrad)
     

Physical Properties

Property ASTM Method Value or Rating
Durometer Hardness (Shore A), 15 sec D2240-02 83
Tensile Strength, psi (MPa) (at break) D412-98 3,595 (41.1)
Ultimate Elongation, %  D412-98 553
Tear Resistance, lb-f/inch (kN/m) D624-91, Die C 509 (83.1)
Compression Set
Constant Deflection, % @ 158°F (70°C) for 22 hours
D395-02, Method B 29
Brittle Temperature, °F (°C) D746-98 < -112 (-80)
Specific Gravity D792-02 1.11
Water Absorption, % 24 hrs at 73°F (23°C)  D570-98 1.13
Maximum Recommended Operating Temperature °F (°C)  n/a 180 (82)
Tensile Modulus @ 100% Elongation, psi (MPa) D412-98 1.546

Characteristics

Tygon MPF-300 has met the following test requirements:

  • Plastic Class VI, as described in USP <88> (2016)
  • Hemocompatibility, as described in ISO 10993-4 (2022)
  • Implantation, as described in ISO 10993-6 (2022)
  • Skin Sensitization, as described in ISO 10993-10 (2022)
  • Acute Systemic Toxicity, as described in ISO 10993-11 (2022)
  • Irritation, as described in ISO 10993-23 (2022)

Related Documents

Download Selected (0)
Thumbnail of Tygon MPF-300 Datasheet
Datasheet
Tygon MPF-300 Technical Datasheet
Get in touch